Jessica Santiccioli
Family · Needham, MANPI 1003338088
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 328 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$922
- Lilly USA, LLC$723
- AbbVie$650
- Boehringer Ingelheim$599
- Pfizer$575
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,87899%
- Education$941%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $1,003 |
| Novo Nordisk | 48 | $922 |
| Lilly USA, LLC | 42 | $723 |
| AbbVie | 34 | $650 |
| Boehringer Ingelheim | 26 | $599 |
| Pfizer | 28 | $575 |
| E.r. Squibb & Sons, L.L.C. | 16 | $374 |
| Astellas Pharma US Inc | 10 | $320 |
| Novartis | 12 | $231 |
| GSK | 8 | $210 |
| Amgen | 7 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $164 |
| Exact Sciences | 7 | $157 |
| Otsuka America Pharmaceutical, Inc. | 6 | $130 |
| VBI Vaccine (delaware) Inc. | 4 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $101 |
| Bayer | 5 | $87 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| QOL Medical, LLC | 2 | $52 |
| Shield Therapeutics Inc | 2 | $42 |
| Ardelyx, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Eisai Inc. | 1 | $24 |
| Teleflex LLC | 1 | $22 |
| Biogen | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Abbott | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $12 |
How this compares
$6,972 in reported general payments places this provider in the 95th percentile of 2,320 family providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $22,036 |
| FarxigaDapagliflozin Propanediol | 19 | $18,554 |
| OzempicSemaglutide | 12 | $16,280 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 45 | $1,180 |
| Omeprazole | 36 | $896 |
| Atorvastatin Calcium | 71 | $857 |
| Ondansetron Hcl | 11 | $737 |
| Lisinopril | 59 | $588 |
| Gabapentin | 34 | $561 |
| Amlodipine Besylate | 77 | $557 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $480 |
| Chlorthalidone | 21 | $453 |
| Metoprolol Succinate | 27 | $393 |
| Metformin Hcl | 43 | $384 |
| Potassium Chloride | 15 | $379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $575 | $22,03617 claims |
| AstraZenecaFarxiga | $1,003 | $18,55419 claims |
| Novo NordiskOzempic | $922 | $16,28012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,320 family providers in Massachusetts.
Other family in Needham
- Paul GouldLakeville$343K
- Brittany MurrayBoston$141K
- Jennifer FlemingLawrence$80K
- Naomi AmudalaBoston$79K
- Geoffrey WhitleyCharlestown$66K
- Katherine O'BrienWinthrop$58K
- Kristy SmithActon$57K
- Leslie StefanowiczDartmouth$56K
- Marissa CasilloFoxborough$31K
- Rochelle NazarianDanvers$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.